Costimulation blockade and Tregs in solid organ transplantation.

Area of Science:

• Immunology
• Transplantation Science
• Pharmacology

Background:

• Regulatory T cells (Tregs) are crucial for immune tolerance in transplantation.
• Costimulation blockers like abatacept/belatacept are approved for transplantation but may affect Tregs.
• Treg function relies on signals from CD28, CTLA4, PD-1, and ICOS.

Purpose of the Study:

• To review the impact of therapeutic costimulation modulation on Treg function in transplantation.
• To explore how current and pipeline costimulation blockers influence Treg homeostasis.
• To understand the consequences for self-tolerance and allo-immune responses.

Main Methods:

• Literature review of studies on costimulation blockers and Treg function.
• Analysis of the effects of CD28, CTLA4, PD-1, and ICOS targeting drugs on Tregs.
• Synthesis of data regarding Treg homeostasis and immune responses in transplantation.

Main Results:

• Costimulation blockers can inhibit effector T cells but may also alter Treg function.
• The specific effects on Tregs depend on the targeted costimulatory or coinhibitory pathway.
• Understanding these effects is vital for optimizing transplant outcomes.

Conclusions:

• Therapeutic manipulation of costimulation presents a complex balance between controlling immune responses and maintaining Treg function.
• Further research is needed to fully elucidate the Treg-specific effects of these therapies.
• Optimizing costimulation blockade strategies may enhance graft survival while preserving self-tolerance.